All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-WFY0764 | Anti-TNFSF18 (XHM539) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | XHM539 | Human | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY1633 | Anti-TNFSF18 (CBFYH-2804) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYH-2804 | Human | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY1634 | Anti-TNFSF18 (CBFYH-2805) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYH-2805 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY4017 | Anti-TNFSF18 (XHM539) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | XHM539 | Human | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY4886 | Anti-TNFSF18 (CBFYH-2804) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBFYH-2804 | Human | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY4887 | Anti-TNFSF18 (CBFYH-2805) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBFYH-2805 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
XS-1222-ZP1222 | TNFSF18 (TNFRSF18 Receptor) h(CD28-CD3ζ) Ligand-based CAR, pCDCAR1 | Human | TNFSF18-CD28-CD6ζ | Lentiviral vector | T cell | ||||
XS-1222-ZP2622 | TNFSF18 (TNFRSF18 Receptor) h(41BB-CD3ζ) Ligand-based CAR, pCDCAR1 | Human | TNFSF18-41BB-CD6ζ | Lentiviral vector | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION